[CUE] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
29-Jun-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- -31.73%
YoY- -216.12%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 26 2,739 1,075 1,055 172 0 0 -
PBT -13,208 -10,279 -10,833 -9,109 -7,300 -4,413 -1,396 45.40%
Tax 118 0 618 413 -170 0 0 -
NP -13,326 -10,279 -10,833 -9,522 -7,300 -4,413 -1,396 45.62%
Tax Rate - - - - - - - -
Total Cost 13,352 13,018 11,908 10,577 7,472 4,413 1,396 45.66%
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin -51,253.85 -375.28 -1,007.72 -902.56 -4,244.19 0.00 0.00 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS -0.38 -0.33 -0.38 -0.46 -0.36 -0.21 -0.19 12.24%
EPS Diluted -0.38 -0.33 -0.38 -0.46 -0.36 -0.21 -0.19 12.24%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.